Medtronic plc (FRA:2M6)

Market Cap	105.86B
Revenue (ttm)	29.14B
Net Income (ttm)	3.97B
Shares Out	n/a
EPS (ttm)	3.08
PE Ratio	26.66
Forward PE	16.72
Dividend	2.54 (3.08%)
Ex-Dividend Date	Sep 26, 2025

Volume	1,200
Average Volume	855
Open	82.59
Previous Close	82.52
Day's Range	82.15 - 82.66
52-Week Range	68.50 - 90.89
Beta	n/a
RSI	56.03
Earnings Date	Nov 18, 2025

About Medtronic

Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients in the United States, Ireland, and internationally. The Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac monitor systems; TYRX products; and remote monitoring and patient-centered software. It also provides aortic valves, surgical valve replacement and repair produc...

• Industry: Electromedical and Electrotherapeutic Apparatus
• Founded: 1949
• Employees: 95,000
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: 2M6

Financial Performance

In 2025, Medtronic's revenue was $33.54 billion, an increase of 3.62% compared to the previous year's $32.36 billion. Earnings were $4.66 billion, an increase of 26.82%.

Financial numbers in USD